Open AccessIs the current use of ‘positivity’ thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?
Author(s) -
Laura Richert,
Rodolphe Thiébaut
Publication year - 2013
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328360d52e
Subject(s) - immunogenicity , medicine , human immunodeficiency virus (hiv) , hiv vaccine , virology , immunology , aids vaccines , vaccine trial , antibody
International audienc